A client receives a new prescription for montelukast. Which information should the nurse include in the client's teaching?

Rationale: A. The medication will prophylactically limit the inflammatory response to allergens: Montelukast is a leukotriene receptor antagonist that blocks leukotriene-mediated inflammation. It is primarily used for reducing airway inflammation and preventing bronchoconstriction before exposure to triggers. B. The medication will contract the smooth muscles located in the respiratory tract: Montelukast does not stimulate contraction of airway smooth muscle. Instead, it helps prevent bronchoconstriction by blocking leukotriene activity, thereby improving airflow. C. Montelukast will increase the production of mucus in the lungs: Excess mucus is part of the inflammatory cascade in asthma, but montelukast reduces this response rather than enhancing it. It decreases airway edema, mucus production, and narrowing of the bronchi. D. Montelukast will help repair damaged tissue in the base of the lungs: This drug is preventive, aimed at controlling asthma symptoms and allergic responses by reducing inflammation, but it cannot reverse structural lung damage.